Dr. Hönle AG

EANS-News: Hönle generated operating profit of EUR 8.3 million in financial year 2011/2012

--------------------------------------------------------------------------------
  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------

annual result

Gräfelfing/Munich (euro adhoc) - According to preliminary figures, Hönle
increased revenue in financial year 2011/2012 by 6.2% to EUR 72.1 million. This
is mainly due to the initial consolidation of Raesch Quarz (Germany) GmbH,
Langewiesen and Raesch Quarz (Malta) Ltd., Malta. Sales in the printing market
were below the previous year's figure due to the insolvency of Manroland AG and
the buying restraint in advance of the Drupa trade fair. The write down of
receivables of insolvent Manroland AG in the amount of EUR 1.1 million in the
first quarter, in addition led to a decrease in operating profit (EBIT) of EUR
11.3 million in fiscal year 2010/2011 to EUR 8.3 million in the financial year
2011/2012. Net profit amounted to EUR 5.4 million in the fiscal year after EUR
7.5 million in the previous year. This corresponds to earnings per share of EUR
0.88 (previous year: EUR 1.30).
Cash and cash equivalents of the Hönle Group amounted to EUR 9.3 million as at
30.09.2012 (PY: EUR 12.9 million). The equity ratio was 60.6%.

In the course of the takeover of the quartz glass specialists Raesch a
reorganization of the business segments of the Hönle Group was made in the
sectors 'equipment and systems', 'adhesives' and 'glass and lamps'. The Hönle
Group generated a turnover of EUR 38.3 million in the segment 'equipment and
systems' (previous year EUR 42.3 million), EUR 15.7 million in the segment
'adhesives' (previous year EUR 17.7 million) and EUR 18.1 million in the segment
'glass and lamps' (previous year: EUR 7,9 million).

The Dr. Hönle AG Management Board and the Supervisory Board plan to have the
shareholders participate in the company's business success and will propose to
the Annual General Meeting that a dividend of EUR 0.50 per share be paid out. 

Outlook:
In the recent years Hönle has emerged from a system manufacturer focusing on the
printing industry into a group of companies, which achieves a majority of their
sales outside the printing industry. The segments 'adhesives' and 'glass and
lamps' offer in interesting markets a huge growth potential.

For the fiscal year 2012/2013 the Management Board aims at generating sales of
EUR 85 million and operating profit of EUR 12 million in the Hönle Group.

Unless the economic conditions deteriorate significantly, the Hönle Group has a
good chance to exceed the turnover threshold of EUR 100 million in the next
three years. In addition to the purely organic growth also the acquisition of
companies for the expansion of business activities of the Hönle Group will be
important.

The final results and the annual report will be published on 14 January 2013.

About Hönle:
Dr. Hönle AG is a listed technology company, headquartered in Gräfelfing near
Munich. The Hönle Group has about 500 employees and is a global leader in UV
technology. The devices are used in drying inks, coatings and adhesives, as well
as in surface disinfection and sunlight simulation. Another focus of the
activities are adhesives and sealants for industrial applications. In addition,
the Group's products include UV lamps for water disinfection and tubes and
semi-finished products made of quartz glass, which are used in different
branches of industry. The Hönle Group is present at about 50 locations in over
20 countries through its own subsidiaries and distribution partners.


Further inquiry note:
Peter Weinert, phone: +49 89 85608 173, mail: peter.weinert@hoenle.de

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


company:     Dr. Hönle AG
             Lochhamer Schlag  1
             D-82166 Gräfeling/München
phone:       +49 89 85608 0
FAX:         +49 89 85608 101
mail:     ir@hoenle.de
WWW:      www.hoenle.de
sector:      Instrument Engineering
ISIN:        DE0005157101
indexes:     CDAX, Prime All Share, Technology All Share
stockmarkets: free trade: Hannover, Berlin, München, Hamburg, Düsseldorf,
             Stuttgart, regulated dealing/prime standard: Frankfurt 
language:   English
 



Weitere Meldungen: Dr. Hönle AG

Das könnte Sie auch interessieren: